Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Whitehawk Therapeutics (Nasdaq: WHWK) announced that Dave Lennon, PhD, President and CEO, will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference in New York City on December 3, 2025 at 12:30 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Whitehawk Therapeutics (Nasdaq: WHWK) announced that Dave Lennon, PhD, President and CEO, will participate in a fireside discussion at the Piper Sandler 37th Annual Healthcare Conference in New York City on December 3, 2025 at 12:30 PM ET. A live webcast will be available on the company's investor relations website and will be replayable for approximately 30 days after the event.
Details
News Market Reaction – WHWK
On Nov 26, the day this news came out, WHWK closed 6.98% above the previous close.
Data tracked by StockTitan Argus for the Nov 26 session.
Key Figures
- Conference edition
- 37th Annual
- Piper Sandler Healthcare Conference
- Event date
- December 3, 2025
- Scheduled conference fireside discussion
- Event time
- 12:30 PM ET
- Start time of fireside chat
- Webcast replay window
- 30 days
- Replay availability after the event
Historical Context
-
Appointment of experienced oncology CMO to support ADC development.
-
Announcement of CEO fireside chat at Piper Sandler healthcare conference.
-
Upcoming CEO presentation at Jefferies Global Healthcare Conference in London.
-
Q3 2025 results with larger net loss despite stronger cash position.
-
Real-world PTK7 expression analysis supporting HWK-007 ADC targeting strategy.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
antibody drug conjugate medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast of the fireside chat can be accessed by visiting the Whitehawk Therapeutics IR website and will be available for replay for approximately 30 days following the event.
About Whitehawk Therapeutics
Whitehawk Therapeutics is an oncology therapeutics company applying advanced technologies to established tumor biology to efficiently deliver improved cancer treatments. Whitehawk's advanced three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers. These assets are in-licensed from
Contact:
IR@whitehawktx.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/whitehawk-therapeutics-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference-302626225.html
SOURCE Whitehawk Therapeutics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.